Some of the top prospects available in the 2026 MLB Draft participated in the MLB Combine. The group mostly consisted of high ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical data from its AI driven drug discovery programs. The company highlighted progress in oncology and rare disease candidates in ...

"We are proud of these recent regulatory achievements, which culminate a year of significant R&D advancement in 2025," said Viatris Chief R&D Officer Philippe Martin. "These important milestones not ...

Welcome to the Foghorn Pipeline Update Conference Call. [Operator Instructions] As a reminder, this webcast is being recorded today, October 30, 2025. I will now turn the call over to Karin Hellsvik, ...

The Milwaukee Brewers have one of the best farm systems in the league, which is a shock considering they're consistently one of the best teams in the big leagues. They had the best record in the ...

With the 2026 season well underway, MLB Pipeline released another revised list of the Top 100 Prospects across Major League Baseball on Wednesday. The most notable change would be at the very top spot ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Good evening, everyone. My name is Arthur Sands. I'm President and CEO of Nurix Therapeutics. And I'd like to welcome you to our 2025 Investor and Analyst event broadcasting here from Orlando, Florida ...

If you buy something from a link, Vox Media may earn a commission. See our ethics statement. MLB Pipeline released their updated top 150 rankings for the 2025 MLB Draft. There is a lot of uncertainty ...

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay ...

There are 11 additional Adimab-associated programs that are currently in Phase II or Phase III (pivotal) trials. The total number of Adimab-associated clinical programs initiated by our partners has ...